4th Course on Breast Cancer

Introduction to breast cancer epidemiology - M. HIS
Breast Imaging : Current Practice - C. MALHAIRE
Classification of breast carcinomas - A. VINCENT-SALOMON
Radiation therapy in breast cancer, less when possible and more when needed - P. POORTMANS
Therapies in HER2+ Breast Cancer - E. BRAIN
Endocrine therapy in Early & Advanced BC - F. LEREBOURS
Therapies in triple negative breast cancer - F. COUSSY

Molecular classification of breast cancer - J. REIS-FILHO
Clinical impact of BRCAness - S. DELALOGE
BRCAness… - MH. STERN
HER2-positive Breast Cancer Lessons from Whole Genome Sequencing : How and When ? - A. VIARI
Mutational signatures: tracking the origins of cancer - S. NIK-ZAINAL
Machine learning approach to model breast cancer networks from heterogeneous data - M. RIBEIRO-DANTAS
Functional interaction between PARP1 and BRCA2 - I. DUMOULIN
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-deficient Cancer Cells by Synthetic Lethality Induction - L. GUANTAY

EMT and Cellular pliancy - A. PUISIEUX
DTC and CTC in breast cancer - JY. PIERGA

BMPs and pollutants: a dual perverse effect on both mammary epithelial stem cells and their niche - V. MAGUER-SATTA
Biology of Estrogen Receptors - M. LE ROMANCER
Breast Cancer Stem Cells - C. GINESTIER
mRNA translation and the resistance to anti-cancer targeted therapies - S. VAGNER
LncRNA and (breast) cancer - A. MORILLON
Machine learning for precision medicine - JP. VERT
Identifying new players of replication fork stability and chemoresistance in homologous recombination deficient tumors - M. TIBOR KOVACS
Monitoring BRCA2 at the replication forks - D. VUGIC

La Recherche Clinique dans l’Industrie Pharmaceutique - F. RINGEISEN
Publishing your paper & the editorial process at EMBO Press - C. CARRET
Mouse models of breast cancer - J. JONKERS
ctDNA - FC. BIDARD